Fundraising Fox
Delphia Therapeutics
Cambridge, US · 24 employees on LinkedIn · 5 known investors
Find your way into Delphia Therapeutics
Sign up to see every warm intro you have to Delphia Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Delphia Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Delphia Therapeutics is a biotechnology company developing cancer medicines based on its activation lethality platform, aiming to create therapies effective on their own while combating resistance to targeted therapies. It focuses on oncology drug discovery and clinical development.
Founders & leadership
Investors · 5
How we know: GV (Google Ventures)'s portfolio page · funding news · gaebler.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Nextech Invest's portfolio page · funding news · gaebler.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · gaebler.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$67M disclosed across 1 round · 2024
- $67MSeries AMay 2024 · 2 sources
Alexandria Venture Investments (lead), GV (lead), Nextech Invest (lead), Polaris Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Delphia Therapeutics do?
- Delphia Therapeutics is a biotechnology company developing cancer medicines based on its activation lethality platform, aiming to create therapies effective on their own while combating resistance to targeted therapies. It focuses on oncology drug discovery and clinical development.
- Who founded Delphia Therapeutics?
- Delphia Therapeutics was founded by Kevin Marks.
- Who are Delphia Therapeutics's investors?
- Delphia Therapeutics's investors include GV (Google Ventures), Nextech Invest, Taiho Ventures, LLC, Alexandria.
- How much funding has Delphia Therapeutics raised?
- Delphia Therapeutics has disclosed $67M raised across 1 round.
- Where is Delphia Therapeutics headquartered?
- Delphia Therapeutics is headquartered in Cambridge, US.